Paclitaxel Treatment Options

A collection of 2016 research studies where Paclitaxel is the interventional treatment. These studies are located in the United States. Paclitaxel is used for conditions such as Breast Cancer, Ovarian Cancer and Non-Small Cell Lung Cancer.

Home

All Treatments

Paclitaxel

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

Featured Trial

Paid Clinical Studies Nationwide

Recruiting

Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.

Conditions:

Healthy

Healthy Volunteer Study

Learn More

* Compensation for time may be available

Featured Trial

Studying an Investigational Virus Vaccine

Recruiting

The main objectives of this study are to assess the safety and effectiveness of an investigational vaccine aimed at preventing norovirus, commonly known as the stomach flu. Participants will be randomly assigned to receive either the investigational vaccine or a placebo. Should you express interest, you will be contacted directly by the research site, which will provide further details and answer any questions you may have about study requirements, risks/benefits, and any compensation.

Conditions:

Healthy

Interested in vaccine studies

All Conditions

Preventative Trials

Learn More

Featured Trial

Type 2 Diabetes Clinical Trial

Recruiting

Can changing your breakfast improve your type 2 diabetes? If you have an HbA1C of 7.0% or higher, you are invited to participate in an online study at the University of Michigan.

Conditions:

Type 2 Diabetes

Diabetes Mellitus Type 2 in Obese

Diabetes Type Two

Type 2 Diabetes Mellitus

Diabete Type 2

Learn More

Featured Trial

Evaluating an Investigational Treatment for Hidradenitis Suppurativa

Recruiting

The main objectives of this Phase 2 study are to evaluate the safety and effectiveness of an investigational medication in adults with moderate to severe hidradenitis suppurativa (HS), a chronic skin condition. Participants will be randomly assigned to receive the investigational treatment or a placebo. Should you express interest, the research site will contact you directly to provide further details and address any questions you may have about study requirements, risks/benefits, and compensation.

Conditions:

All Conditions

Hidradenitis suppurativa (Skin disorder)

Dermatology

Learn More

Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Adults Receiving First Cytotoxic Chemotherapy for Metastatic or Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC) and Who Are Current or Former Smokers

NCT02264990

Completed

The purpose of this study is to evaluate the safety and efficacy of veliparib plus carboplatin and paclitaxel versus the Investigator's choice of standard chemotherapy in adults with metastatic or advanced non-squamous non-small cell lung cancer.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

02/08/2021

Locations: Clearview Cancer Institute /ID# 131434, Huntsville, Alabama +139 locations

Clearview Cancer Institute /ID# 131434, Huntsville, Alabama

University of South Alabama /ID# 131518, Mobile, Alabama

Highlands Oncology Group /ID# 131250, Springdale, Arkansas

CBCC Global Research, Inc. at /ID# 132709, Bakersfield, California

California Cancer Assoc. R&E /ID# 131392, Encinitas, California

California Cancer Assoc. R&E /ID# 131949, Encinitas, California

LA Hem-Oncology Med Group /ID# 131639, Los Angeles, California

St Jude Hospital dba St Joseph /ID# 132943, Santa Rosa, California

Icri /Id# 132942, Whittier, California

University of Florida - Archer /ID# 132408, Gainesville, Florida

NorthShore University HealthSystem - Evanston Hospital /ID# 130200, Evanston, Illinois

Goshen Center for Cancer Care /ID# 130216, Goshen, Indiana

University of Louisville /ID# 130217, Louisville, Kentucky

Cancer Center of Acadiana /ID# 133611, Lafayette, Louisiana

Henry Ford Health System /ID# 130234, Detroit, Michigan

Herbert Herman Cancer Center /ID# 130239, Lansing, Michigan

Washington University-School of Medicine /ID# 131651, Saint Louis, Missouri

MD Anderson Cancer Center at Cooper - Camden /ID# 131490, Camden, New Jersey

Gabrail Cancer Center Research /ID# 130205, Canton, Ohio

Univ Oklahoma HSC /ID# 132888, Oklahoma City, Oklahoma

Albert Einstein Medical Center /ID# 134498, Philadelphia, Pennsylvania

Allegheny General Hospital /ID# 134049, Pittsburgh, Pennsylvania

The Jones Clinic, PC /ID# 130215, Germantown, Tennessee

UT Southwestern Medical Center /ID# 130236, Dallas, Texas

Univ Texas HSC San Antonio /ID# 132972, San Antonio, Texas

Coiba /Id# 132153, Berazategui, Buenos Aires, Not set

Centro Investigacion Pergamino /ID# 132152, Pergamino, Not set

Hospital Britanico /ID# 134874, Rosario, Santa FE, Not set

Instituto de Oncologia de Rosa /ID# 132150, Rosario, Santa FE, Not set

St George Hospital /ID# 132481, Kogarah, New South Wales

Southern Medical Day Care Ctr /ID# 132482, Wollongong, New South Wales

Flinders Centre for Innovation /ID# 134288, Bedford Park, South Australia

Royal Hobart Hospital /ID# 132477, Hobart, Tasmania

Qe Ii Hsc /Id# 133408, Halifax, Nova Scotia

Victoria Hospital /ID# 132161, London, Ontario

Windsor Regional Hospital /ID# 135989, Windsor, Ontario

CSSS Alphonse-Desjardins, CHAU de Levis /ID# 132155, Quebec City, Quebec

Krajska nemocnice Liberec a.s. /ID# 132694, Liberec, Not set

Univ Hosp Ostrava-Poruba /ID# 132690, Ostrava, Not set

Multiscan s.r.o. /ID# 132689, Pardubice, Not set

Vseobecna Fakultni Nemocnice /ID# 135118, Prague, Not set

Odense Universitets Hospital /ID# 131912, Odense C, Syddanmark

Satakunnan Sairaanhoitopiiri /ID# 133632, Pori, Not set

Vaasa Central Hospital /ID# 131930, Vaasa, Not set

Charite-Univ. Berlin, Benjamin-Franklin /ID# 131927, Berlin, Not set

Lungen Clinic Grosshansdorf /ID# 131928, Grosshansdorf, Not set

Univ Klinik Eppendorf Hamburg /ID# 131926, Hamburg, Not set

Klinik Loewenstein GmbH /ID# 131925, Löwenstein, Not set

CRU Hungary Egeszsegugyi és Szolgaltato Kft. /ID# 133441, Miskolc, Borsod-Abauj-Zemplen

Orszagos Koranyi Pulmonologiai Intezet /ID# 132738, Budapest XII, Budapest

Debreceni Egyetem Klinikai Kozpont /ID# 132742, Debrecen, Not set

Koch Robert Hospital /ID# 133440, Edelény, Not set

Veszprem Megyei Tudogyogyintez /ID# 132739, Farkasgyepu, Not set

Petz Aladar Megyei Oktato Korh /ID# 132741, Gyor, Not set

Matrahaza Gyogyintezet /ID# 132743, Kékesteto, Not set

Assaf Harofeh Medical Center /ID# 132830, Be'er Ya'akov, Not set

Shaare Zedek Medical Center /ID# 132834, Jerusalem, Not set

Meir Medical Center /ID# 132832, Kfar Saba, Not set

Sheba Medical Center /ID# 132833, Ramat Gan, Not set

Aichi Cancer Center Hospital /ID# 134129, Nagoya-shi, Aichi

Kurume University Hospital /ID# 134117, Kurume-shi, Fukuoka

Hokkaido University Hospital /ID# 134123, Sapporo-shi, Hokkaido

Kanagawa Cardiovascular and Respiratory Center /ID# 134127, Yokohama-shi, Kanagawa

Sendai Kousei Hospital /ID# 135491, Sendai-shi, Miyagi

Kindai University Hospital /ID# 134112, Osaka-sayama-shi, Osaka

Osaka City General Hospital /ID# 134115, Osaka-shi, Osaka

National Cancer Center Hospital /ID# 135129, Chuo-ku, Tokyo

The Cancer Institute Hospital Of JFCR /ID# 135492, Koto-ku, Tokyo

Yamaguchi - Ube Medical Center /ID# 135284, Ube-shi, Yamaguchi

Hiroshima Citizens Hospital /ID# 135130, Hiroshima, Not set

Kishiwada City Hospital /ID# 136548, Kishiwada, Not set

Dong-A University Hospital /ID# 131609, Busan, Busan Gwang Yeogsi

Seoul National Univ Bundang ho /ID# 131610, Seongnam, Gyeonggido

Inha University Hospital /ID# 147924, Jung-gu, Incheon Gwang Yeogsi

Chonnam National University Hospital /ID# 131612, Gwangju, Jeonranamdo

Samsung Medical Center /ID# 132471, Seoul, Seoul Teugbyeolsi

Chungbuk National Univ Hosp /ID# 131611, Cheongju, Not set

Vrije Universiteit Medisch Centrum /ID# 131967, Amsterdam, Not set

Catharina Ziekenhuis /ID# 131966, Eindhoven, Not set

Ziekenhuis St. Jansdal /ID# 131965, Harderwijk, Not set

St. Antonius Ziekenhuis /ID# 133635, Nieuwegein, Not set

Jeroen Bosch Ziekenhuis /ID# 131968, S Hertogenbosch, Not set

Canterbury District Health Boa /ID# 132469, Christchurch, Not set

Wellington Hospital (Capital and Coast District Health Board) /ID# 132470, Wellington, Not set

Federal State Budgetary Scientific Institution N.N. Blokhin Russian Cancer Resea /ID# 137085, Moscow, Moskva

Sverdlovsk Regional Oncology Center Dispensary /ID# 132375, Ekaterinburg, Sverdlovskaya Oblast

archangel Clinical Oncology /ID# 132376, Arkhangelsk, Not set

Moscow Regional Onc Dispensary /ID# 132381, Balashikha, Not set

Belgorod Oncology Dispensary /ID# 142638, Belgorod, Not set

Moscow Res Onc Inst Hertsen /ID# 132370, Moscow, Not set

State Regional Budgetary Healthcare Institution " Murmansk Regional Oncology Dis /ID# 137087, Murmansk, Not set

Orenburg Regional Clinical Onc /ID# 132371, Orenburg, Not set

Strategic medical systems LLC /ID# 206383, Sankt-Peterburg, Not set

Ogarev Mordovia State Univ /ID# 132377, Saransk, Not set

LLC BioEq Ltd. /ID# 132372, St. Petersburg, Not set

N.N. Petrov Research Inst Onc /ID# 137084, St. Petersburg, Not set

GVI Oncology /ID# 133268, Port Elizabeth, Eastern Cape

Dr Albert, Bouwer and Jordaan Incorporated /ID# 131775, Pretoria, Gauteng

Mary Potter Oncology Centre /ID# 131776, Pretoria, Gauteng

The Oncology Centre /ID# 131773, Durban, Kwazulu-Natal

Netcare Oncology Intervent Ctr /ID# 131777, Cape Town, Western Cape

Cape Town Oncology Trials /ID# 132734, Cape Town, Western Cape

GVI Rondebosch Oncology Centre /ID# 132732, Cape Town, Western Cape

Sandton Oncology Medical Group /ID# 131774, Johannesburg, Not set

Hospital Duran i Reynals /ID# 132879, L'Hospitalet de Llobregat, Barcelona

Hospital Universitario Fundacion Alcorcon /ID# 132909, Alcorcon, Not set

Hospital General Universitario Alicante /ID# 132881, Alicante, Not set

Hospital Universitario Dexeus - Grupo Quironsalud /ID# 132876, Barcelona, Not set

Hospital Universitario Vall d'Hebron /ID# 132871, Barcelona, Not set

MD Anderson Madrid /ID# 132905, Madrid, Not set

Hospital Universitario La Paz /ID# 132870, Madrid, Not set

Hospital Universitario HM Sanchinarro /ID# 132869, Madrid, Not set

Hospital Clinico Universitario de Valencia /ID# 132873, Valencia, Not set

China Medical University Hosp /ID# 131870, Taichung City, Taichung

Dalin Tzu Chi General Hospital /ID# 131872, Dalin Township, Not set

Taipei Medical University Hospital /ID# 133817, Taipei City, Not set

Taipei Veterans General Hosp /ID# 131871, Taipei City, Not set

Hacettepe University Medical Faculty /ID# 131913, Ankara, Not set

Ankara Univ Medical Faculty /ID# 131914, Ankara, Not set

Uludag University Medical Faculty /ID# 131915, Bursa, Not set

Dicle Universitesi Tip /ID# 136570, Diyarbakir, Not set

Gaziantep Universitesi Med /ID# 131917, Gaziantep, Not set

Dr. Suat Seren Gogus Has /ID# 136568, Izmir, Not set

Inonu University /ID# 136569, Malatya, Not set

Leicester Royal Infirmary /ID# 133930, Leicester, England

Cheltenham General Hospital /ID# 131951, Cheltenham, Gloucestershire

Norfolk and Norwich Univ Hosp /ID# 131953, Norwich, Norfolk

Royal United Hospitals Bath /ID# 132851, Bath, Not set

Belfast City Hospital /ID# 132858, Belfast, Not set

Heart of England NHS Foundation Trust /ID# 132855, Birmingham, Not set

Royal Blackburn Hospital /ID# 132853, Blackburn, Not set

Colchester General Hospital /ID# 133929, Colchester, Not set

Castle Hill Hospital /ID# 135489, Cottingham, Not set

Scunthorpe General Hospital /ID# 133931, Doncaster, Not set

James Paget University Hosp /ID# 131954, Great Yarmouth, Not set

Royal Gwent Hospital /ID# 133935, Gwent, Not set

Huddersfield Royal Infirmary /ID# 132854, Huddersfield, Not set

Charing Cross Hospital /ID# 131959, London, Not set

The Newcastle Upon Tyne Hospitals NHS Foundation Trust Freeman Hospital /ID# 131661, Newcastle Upon Tyne, Not set

York Hospital /ID# 132859, York, Not set

Conditions: Non-squamous Non-small Cell Lung Cancer

Learn More ›

Tipifarnib and Combination Chemotherapy in Treating Patients With Stage II or Stage III Breast Cancer

NCT00470301

Completed

Tipifarnib may stop the growth of breast cancer by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor. Drugs used in chemotherapy, such as paclitaxel, doxorubicin, and cyclophosphamide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving tipifarnib together with combination chemotherapy may kill more tumor cells. This phase I/II trial is studying the side effects and best dose of... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

01/29/2021

Locations: H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida +6 locations

Conditions: Breast Cancer, Male Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer

Learn More ›

Alternative Neoadjuvant Chemotherapy in Resectable and Borderline Resectable Pancreatic Cancer

NCT03703063

Unknown

Using alternative neoadjuvant gemcitabine-nab-paclitaxel and nal-IRI with 5-Fluorouracil (5FU) and folinic acid (Leucovorin) regimens of localized cancer, we hope to ensure exposure of the cancer to a broader array of potentially active agents. Also, potentially improves patient tolerance and minimizes significant drug toxicity that could impair delivery of all treatment elements. Furthermore, it may enable prediction of superior to inferior treatment outcomes at an earlier point in the disease... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

01/25/2021

Locations: Virginia mason medical Center, Seattle, Washington

Conditions: Pancreatic Adenocarcinoma

Learn More ›

Neoadjuvant Therapy for Ovarian Cancer

NCT01146795

Completed

This study is to determine the feasibility of administering neoadjuvant carboplatin, paclitaxel, and bevacizumab without excessive dose modification or cycle delay in patients with epithelial ovarian cancer, primary peritoneal cancer or fallopian tube cancer. This study will also investigate the rate of optimal cytoreduction, response rate and progression free and overall survival, and to assess the quality of life for patients with epithelial ovarian cancer, primary peritoneal cancer or fallopi... Read More

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

01/20/2021

Locations: Columbia University Medical Center, New York, New York +2 locations

Conditions: Epithelial Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer

Learn More ›

A Study Evaluating Safety and Efficacy of the Addition of ABT-888 Plus Carboplatin Versus the Addition of Carboplatin to Standard Chemotherapy Versus Standard Chemotherapy in Subjects With Early Stage Triple Negative Breast Cancer

NCT02032277

Completed

This is a 3 arm Phase 3 study to evaluate the safety and efficacy of the addition of veliparib plus carboplatin versus the addition of carboplatin to standard neoadjuvant chemotherapy versus standard neoadjuvant chemotherapy in subjects with early stage TNBC.

Gender:

FEMALE

Ages:

Between 18 years and 99 years

Trial Updated:

01/15/2021

Locations: Scottsdale Healthcare /ID# 120473, Scottsdale, Arizona +157 locations

Scottsdale Healthcare /ID# 120473, Scottsdale, Arizona

Mayo Clinic - Scottsdale /ID# 139932, Scottsdale, Arizona

Arizona Oncology Associates, PC-HOPE /ID# 126137, Tucson, Arizona

Usc /Id# 123310, Los Angeles, California

Pacific Cancer Care /ID# 120476, Salinas, California

Sharp Memorial Hospital /ID# 119861, San Diego, California

Stanford University School of Med /ID# 130316, Stanford, California

Cedars-Sinai Medical Center - West Hollywood /ID# 137275, West Hollywood, California

Christiana Care Health Service /ID# 137823, Newark, Delaware

Florida Cancer Specialists - Fort Myers /ID# 121835, Fort Myers, Florida

Florida Cancer Specialists - Fort Myers /ID# 126379, Fort Myers, Florida

Mayo Clinic /ID# 132349, Jacksonville, Florida

Mount Sinai Comp Cancer Ctr /ID# 133008, Miami, Florida

Miami Cancer Institute - Baptist Health South Florida /ID# 126145, Miami, Florida

UF Health Cancer Center /ID# 141589, Orlando, Florida

Moffitt Cancer Center /ID# 124063, Tampa, Florida

University of Illinois - Chicago /ID# 134329, Chicago, Illinois

Northwestern University Feinberg School of Medicine /ID# 133848, Chicago, Illinois

University of Chicago DCAM /ID# 120467, Chicago, Illinois

Loyola University Medical Ctr /ID# 120455, Maywood, Illinois

OSF St. Anthony Medical Center /ID# 139424, Rockford, Illinois

Indiana Univ School Medicine /ID# 118215, Indianapolis, Indiana

Community Rgnal Cancer Care N /ID# 120456, Indianapolis, Indiana

Horizon Oncology Research Center /ID# 116815, Lafayette, Indiana

Cancer Center of Kansas /ID# 134720, Wichita, Kansas

Univ Maryland School Medicine /ID# 119235, Baltimore, Maryland

St. Joseph Mercy Hospital /ID# 135875, Ypsilanti, Michigan

Minnesota Oncology Hematology, PA /ID# 126144, Minneapolis, Minnesota

St. Lukes Cancer Institute /ID# 118775, Kansas City, Missouri

Comprehensive Cancer Ctrs Neva /ID# 126136, Las Vegas, Nevada

Solinksy Center for Cancer Care /ID# 131970, Manchester, New Hampshire

Rutgers Cancer Institute of NJ /ID# 120477, New Brunswick, New Jersey

Columbia Univ Medical Center /ID# 141588, New York, New York

Hope Womens Cancer Centers /ID# 119179, Asheville, North Carolina

Univ NC Chapel Hill /ID# 132893, Chapel Hill, North Carolina

Univ NC Chapel Hill /ID# 147695, Chapel Hill, North Carolina

Novant Health Oncology Special /ID# 139890, Winston-Salem, North Carolina

Sanford Roger Maris Cancer Cen /ID# 132394, Fargo, North Dakota

Oncology Hematology Care, Inc - Blue Ash /ID# 120478, Cincinnati, Ohio

University Hospitals Case Medical Center /ID# 141691, Cleveland, Ohio

Fairview Hospital /ID# 141626, Cleveland, Ohio

Cleveland Clinic Main Campus /ID# 126378, Cleveland, Ohio

The Ohio State University /ID# 141587, Columbus, Ohio

Lehigh Valley Health Network /ID# 133372, Allentown, Pennsylvania

Guthrie Medical Group, PC /ID# 124397, Sayre, Pennsylvania

Women and Infants Hospital /ID# 123476, Providence, Rhode Island

Avera Cancer Institute /ID# 120466, Sioux Falls, South Dakota

Tennessee Oncology, PLLC /ID# 124566, Nashville, Tennessee

Texas Oncology - Bedford /ID# 126135, Bedford, Texas

Texas Oncology - Medical City Dallas /ID# 126140, Dallas, Texas

Texas Oncology - Medical City Dallas /ID# 126141, Dallas, Texas

UT Southwestern Medical Center /ID# 133849, Dallas, Texas

The Ctr for Cancer and Blood D /ID# 120479, Fort Worth, Texas

Texas Oncology - Memorial City /ID# 126139, Houston, Texas

Texas Oncology - Plano East /ID# 126143, Plano, Texas

Texas Oncology - Tyler /ID# 126142, Tyler, Texas

University of Utah /ID# 118677, Salt Lake City, Utah

University of Virginia /ID# 122975, Charlottesville, Virginia

Virginia Commonwealth Univ /ID# 141586, Richmond, Virginia

Virginia Oncology Associates /ID# 127260, Virginia Beach, Virginia

Univ of Wisconsin Hosp/Clinics /ID# 120457, Madison, Wisconsin

The Tweed Hospital /ID# 120235, Tweed Heads, New South Wales

Cabrini Health /ID# 120236, Malvern, Victoria

Royal Melbourne Hospital /ID# 127717, Parkville, Victoria

Western Health Sunshine Hosp. /ID# 120715, St. Albans, Victoria

Fiona Stanley Hospital /ID# 120716, Murdoch, Western Australia

St. John of God Hosp - Murdoch /ID# 131788, Murdoch, Western Australia

St. John of God Subiaco Hosp /ID# 120717, Subiaco, Western Australia

Cliniques Universitaires Saint Luc /ID# 120719, Woluwe-Saint-Lambert, Bruxelles-Capitale

Grand Hôpital de Charleroi /ID# 116678, Charleroi, Hainaut

CHU Brugmann /ID# 120376, Brussels, Not set

UZ Antwerp /ID# 120720, Edegem, Not set

AZ Groeninge /ID# 120718, Kortrijk, Not set

CHU UCL Namur /ID# 116677, Namur, Not set

Sunnybrook Health Sciences Ctr /ID# 123312, Toronto, Ontario

Jewish General Hospital /ID# 141629, Montreal, Quebec

CHUM - Notre-Dame Hospital /ID# 141694, Montréal, Quebec

CHUQ-Hospital St. Sacrement /ID# 141619, Quebec City, Quebec

Fakultni Nemocnice Olomouc /ID# 120725, Olomouc, Olomoucky Kraj

Masarykuv onkologikcy ustav /ID# 120726, Brno, Not set

FN Hradec Kralove /ID# 120596, Hradec Kralove, Not set

Hopital Universitaire Purpan /ID# 120731, Toulouse, Haute-Garonne

Centre Oscar Lambret /ID# 119958, Lille, Hauts-de-France

Institut Curie /ID# 116679, Paris CEDEX 05, Ile-de-France

Centre Leon Berard /ID# 120740, Lyon CEDEX 08, Rhone

Jean Perrin Centre /ID# 125277, Clermont Ferrand, Not set

Hosp European, Georges Pompid /ID# 120736, Paris, Not set

Hopital Rene Huguenin /ID# 120729, Saint-cloud, Not set

Universitaetsklinikum Schleswig-Holstein /ID# 133454, Kiel, Schleswig-Holstein

Universitaetsklinikum Ulm /ID# 133453, Ulm, Thueringen

Gemeinschaftspraxis Dr. Heinrich und Prof. Bangerter /ID# 133472, Augsburg, Not set

Helios Klinikum Berlin Buch /ID# 133465, Berlin, Not set

Studiengesellschaft Onk Bielef /ID# 133471, Bielefeld, Not set

Klinikum Bremen Mitte gGmbH /ID# 132875, Bremen, Not set

St. Johannes Hospital /ID# 133478, Dortmund, Not set

Kliniken Esslingen /ID# 133475, Esslingen, Not set

Klinikum Frankfurt Hoechst /ID# 145301, Frankfurt, Not set

Wilke/Wagner/Petzoldt, Fuerth /ID# 133481, Fürth, Not set

Evangelisches Krankenhaus /ID# 133457, Gelsenkirchen, Not set

Elisabeth Krankenhaus /ID# 133461, Kassel, Not set

St. Vincenz Krankenhaus /ID# 133466, Limburg, Not set

Onk Zentrum am Rotkreuz /ID# 133482, Munich, Not set

Klinikum recht der Isar der TU /ID# 133449, Munich, Not set

Sana Klinikum Offenbach /ID# 133455, Offenbach, Not set

Leopoldina-Krankenhaus /ID# 133484, Schweinfurt, Not set

Johanniter-Krankenhaus Genthin /ID# 133463, Stendal, Not set

St. Josefs-Hospital /ID# 133464, Wiesbaden, Not set

Marienhospital Witten /ID# 133470, Witten, Not set

National Institute of Oncology /ID# 120828, Budapest, Not set

Magyar Honvedseg Egeszsegugyi Kozpont /ID# 120834, Budapest, Not set

Uzsoki Utcai Korhaz /ID# 120825, Budapest, Not set

Debreceni Egyetem Klinikai Kozpont /ID# 116681, Debrecen, Not set

Petz Aladar Megyei Oktato Korh /ID# 120835, Gyor, Not set

Bacs-Kiskun Megyei Korhaz /ID# 120833, Kecskemét, Not set

BAZ Megyei E.O. Korhaz /ID# 122215, Miskolc, Not set

University of Szeged /ID# 120823, Szeged, Not set

Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz /ID# 120818, Szolnok, Not set

A.O.U. Policlinico S.Orsola-Malpighi /ID# 122855, Bologna, Emilia-Romagna

Misericordia General Hospital /ID# 119536, Grosseto, Not set

IRCCS-I.R.S.T. srl Meldola /ID# 120255, Meldola, Not set

Istituto Europeo di Oncologia /ID# 120845, Milan, Not set

IRCCS Fondazione Salva Maugeri /ID# 120848, Pavia, Not set

National Cancer Center /ID# 119525, Goyang, Gyeonggido

Ajou University Hospital /ID# 118856, Suwon-si, Gyeonggido

Kyungpook National University Chilgok Hospital /ID# 118855, Daegu, Seoul Teugbyeolsi

Severance Hospital /ID# 116699, Seoul, Seoul Teugbyeolsi

Samsung Medical Center /ID# 119276, Seoul, Seoul Teugbyeolsi

Korea University Anam Hospital /ID# 118857, Seoul, Not set

Seoul National University Hospital /ID# 116698, Seoul, Not set

Asan Medical Center /ID# 116696, Seoul, Not set

Vrije Universiteit Medisch Centrum /ID# 126302, Amsterdam, Not set

Federal State Budgetary Scientific Institution N.N. Blokhin Russian Cancer Resea /ID# 120944, Moscow, Moskva

Kursk Regional Oncology Dispen /ID# 116688, Kursk, Tatarstan, Respublika

archangel Clinical Oncology /ID# 120935, Arkhangelsk, Not set

Medical Radiological Res Ctr /ID# 124017, Obninsk, Not set

Pyatigorsk Oncology Dispensary /ID# 120945, Pyatigorsk, Not set

Leningrad Reg Onc Dispensery /ID# 120938, St. Petersburg, Not set

Birch A Healthcare /ID# 116695, St. Petersburg, Not set

Hospital Universitario A Coruña - CHUAC /ID# 135108, A Coruña, A Coruna

Hospital Universitario Germans Trias i Pujol /ID# 135112, Badalona, Barcelona

Hospital General Universitario Alicante /ID# 135115, Alicante, Not set

Hospital Parc de Salut del Mar /ID# 135110, Barcelona, Not set

Hospital Santa Creu i Sant Pau /ID# 145400, Barcelona, Not set

Hospital Universitario Arnau de Vilanova de Lleida /ID# 120979, Lleida, Not set

Hospital Universitario Ramon y Cajal /ID# 135113, Madrid, Not set

Hospital Clinico Universitario San Carlos /ID# 119959, Madrid, Not set

Hospital Universitario Virgen del Rocio /ID# 135114, Sevilla, Not set

Fundacion Instituto Valenciano Oncologia IVO /ID# 135116, Valencia, Not set

Hospital Clinico Universitario de Valencia /ID# 123076, Valencia, Not set

Hospital General Universitario de Valencia /ID# 135111, Valencia, Not set

Hospital Universitario Miguel Servet /ID# 119195, Zaragoza, Not set

National Taiwan Univ Hosp /ID# 122895, Taipei City, Taipei

Changhua Christian Hospital /ID# 119085, Changhua County, Not set

Chi Mei Hospital - Liouying /ID# 120982, Tainan City, Not set

Univ Hosp Bristol NHS Foundati /ID# 120989, Bristol, Not set

Charing Cross Hospital /ID# 120990, London, Not set

Nottingham Univ Hospitals NHS /ID# 122218, Nottingham, Not set

Royal Stoke Univ Hospital /ID# 120984, Stoke on Trent, Not set

Conditions: Triple Negative Breast Cancer

Learn More ›

ACY-1215 + Nab-paclitaxel in Metastatic Breast Cancer

NCT02632071

Completed

This is a non-randomized phase 1 trial designed to determine the MTD and evaluate the safety and tolerability of ACY-1215 with nab-paclitaxel. Based on the activity profile of ACY-1215 in breast cancer, corresponding biomarker availability with the HDAC6 MR score, and its potential synergy with taxanes, these data support the rationale for testing the ability of ACY-1215 to improve the response rate for patients with metastatic breast cancer in combination with standard taxane chemotherapy.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

01/05/2021

Locations: Columbia Irving University Medical Center, New York, New York

Conditions: Metastatic Breast Cancer, Breast Carcinoma

Learn More ›

Gemcitabine, Paclitaxel and Oxaliplatin (GemPOx)

NCT01270724

Completed

This study will look to see how well patients with relapsed or recurrent intracranial germ cell tumors respond to the new combination of chemotherapy (in induction)of Gemcitabine, Paclitaxel and Oxaliplatin (GemPOx) followed by consolidation chemotherapy and autologous stem cell rescue.

Gender:

ALL

Ages:

All

Trial Updated:

01/05/2021

Locations: Phoenix Children's Hospital, Phoenix, Arizona +4 locations

Conditions: CNS Germ Cell Tumor

Learn More ›

A Trial of ZD6474, Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiation Therapy Followed by Surgery

NCT01183559

Completed

The purpose of the study is to determine the most tolerable and safe dose of ZD6474 (Zactima, Vandetanib) when given with standard chemotherapy, radiation therapy and surgery in patients with cancer of the esophagus

Gender:

ALL

Ages:

18 years and above

Trial Updated:

01/04/2021

Locations: Fox Chase Cancer Center, Philadelphia, Pennsylvania

Conditions: Cancer of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Cancer of the Stomach

Learn More ›

Doxorubicin HCL Liposome Injection (DOXIL) in Combination With Abraxane in Patients With Metastatic Breast Cancer

NCT00442260

Completed

Dose Finding and Efficacy Evaluation of DOXIL (Doxorubicin HCL Liposome Injection) in Combination with Abraxane (Abraxane) in Patients with Metastatic Breast Cancer (MBC) \[Phase I and II\]

Gender:

ALL

Ages:

18 years and above

Trial Updated:

12/22/2020

Locations: Clinical Trials Research Unit, West Virginia University, Morgantown, West Virginia

Conditions: Metastatic Breast Cancer

Learn More ›

Albumin-Bound Paclitaxel and Gemcitabine in Patients With Untreated Stage IV or Recurrent Squamous Cell Lung Cancers

NCT02525653

Completed

The purpose of this study is to test the safety and effectiveness of albumin-bound paclitaxel plus gemcitabine in patients with advanced squamous cell lung cancers. The investigators would like to determine the percentage of patients with squamous cell lung cancers who experience shrinkage of their tumors following treatment with this regimen. This combination of drugs is not a standard therapy for patients with squamous cell lung cancers. However, each of these drugs, when given alone or with o... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

12/21/2020

Locations: Miami Cancer Institute Baptist Health South Florida, Miami, Florida +5 locations

Conditions: Lung Cancer, Untreated Stage IV or Recurrent Squamous Cell Lung Cancers

Learn More ›

A Trial l of Panobinostat Given in Combination With Trastuzumab and Paclitaxel in Adult Female Patients With HER2 Positive Metastatic Breast Cancer

NCT00788931

Completed

The primary purpose of this study is to identify the maximum tolerated dose (MTD) of both intravenous and oral panobinostat when given in combination with trastuzumab and paclitaxel. The study will evaluate safety and efficacy of the combination in adult female patients with HER2+ metastatic breast cancer

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

12/16/2020

Locations: Novartis Investigative Site, Mobile, Alabama +6 locations

Conditions: HER-2 Positive Breast Cancer, Metastatic Breast Cancer

Learn More ›

A Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid Tumors

NCT01240655

Completed

This is a dose escalation study that will assess the safety and efficacy of LCL161 in combination with weekly paclitaxel in adult patients with advanced solid tumors.

Gender:

ALL

Ages:

Between 18 years and 100 years

Trial Updated:

12/16/2020

Locations: Dana Farber Cancer Institute SC, Boston, Massachusetts +6 locations

Conditions: Solid Tumors

Learn More ›

Browse by State

Paclitaxel treatment options in Alabama

Paclitaxel treatment options in Alaska

Paclitaxel treatment options in Arizona

Paclitaxel treatment options in Arkansas

Paclitaxel treatment options in California

Paclitaxel treatment options in Colorado

Paclitaxel treatment options in Connecticut

Paclitaxel treatment options in Delaware

Paclitaxel treatment options in District of Columbia

Paclitaxel treatment options in Florida

Paclitaxel treatment options in Georgia

Paclitaxel treatment options in Hawaii

Paclitaxel treatment options in Idaho

Paclitaxel treatment options in Illinois

Paclitaxel treatment options in Indiana

Paclitaxel treatment options in Iowa

Paclitaxel treatment options in Kansas

Paclitaxel treatment options in Kentucky

Paclitaxel treatment options in Louisiana

Paclitaxel treatment options in Maine

Paclitaxel treatment options in Montana

Paclitaxel treatment options in Nebraska

Paclitaxel treatment options in Nevada

Paclitaxel treatment options in New Hampshire

Paclitaxel treatment options in New Jersey

Paclitaxel treatment options in New Mexico

Paclitaxel treatment options in New York

Paclitaxel treatment options in North Carolina

Paclitaxel treatment options in North Dakota

Paclitaxel treatment options in Ohio

Paclitaxel treatment options in Oklahoma

Paclitaxel treatment options in Oregon

Paclitaxel treatment options in Maryland

Paclitaxel treatment options in Massachusetts

Paclitaxel treatment options in Michigan

Paclitaxel treatment options in Minnesota

Paclitaxel treatment options in Mississippi

Paclitaxel treatment options in Missouri

Paclitaxel treatment options in Pennsylvania

Paclitaxel treatment options in Rhode Island

Paclitaxel treatment options in South Carolina

Paclitaxel treatment options in South Dakota

Paclitaxel treatment options in Tennessee

Paclitaxel treatment options in Texas

Paclitaxel treatment options in Utah

Paclitaxel treatment options in Vermont

Paclitaxel treatment options in Virginia

Paclitaxel treatment options in Washington

Paclitaxel treatment options in West Virginia

Paclitaxel treatment options in Wisconsin

Paclitaxel treatment options in Wyoming